Perspective Therapeutics
Price & Volume
Stats
See moreOpen | $5.10 |
Previous Close | $5.06 |
Day Range | $5-$5.23 |
52W Range | $1.60-$6.16 |
Market Cap | $632.2M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $1M |
Revenue Growth (YoY) | -43.4% |
Gross Profit (12 Mos) | -$60.8M |
Diluted EPS | -$1.51 |
News
See moreYahoo Finance • 25 days ago
Perspective Therapeutics Announces Pricing of $175 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Yahoo Finance • 2 months ago
Perspective Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Yahoo Finance • 3 months ago
Perspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the ASCO Gastrointestinal Cancers Symposium
Yahoo Finance • 4 months ago
Perspective Therapeutics Provides Recent Business Highlights and Reports 3Q 2025 Results
About
CEO | Mr. Johan M. Spoor |
Address | 2401 Elliott Avenue, Seattle, WA, United States, 98121 |
Sector | Healthcare |
Industry | Medical Devices |
Full-Time Employees | 138 |
